3,4-Dimethoxyamphetamine
| Clinical data | |
|---|---|
| Other names | 3,4-DMA; Dimethoxyamphetamine; DMA; 3,4-Dimethoxy-α-methylphenethylamine; O,O-Dimethyl-α-methyldopamine; α-Methylhomoveratrylamine; EA-1316; NSC-144717 |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen; Sympathomimetic |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.003.985 |
| Chemical and physical data | |
| Formula | C11H17NO2 |
| Molar mass | 195.262 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3,4-Dimethoxyamphetamine (3,4-DMA), or simply dimethoxyamphetamine (DMA), is a psychedelic drug of the phenethylamine and amphetamine families. It is one of the dimethoxyamphetamine (DMA) series of positional isomers.
Category:
- Drugs not assigned an ATC code